Sweden · Delayed Price · Currency is SEK Mycronic AB Statistics
Total Valuation
Mycronic AB has a market cap or net worth of SEK 64.52 billion. The enterprise value is 62.25 billion.
| Market Cap | 64.52B |
| Enterprise Value | 62.25B |
Important Dates
The next confirmed earnings date is Thursday, October 22, 2026.
| Earnings Date | Oct 22, 2026 |
| Ex-Dividend Date | May 7, 2026 |
Share Statistics
Mycronic AB has 195.27 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 195.27M |
| Shares Outstanding | 195.27M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 0.17% |
| Owned by Institutions (%) | 52.03% |
| Float | 150.39M |
Valuation Ratios
The trailing PE ratio is 37.21 and the forward PE ratio is 34.29. Mycronic AB's PEG ratio is 3.27.
| PE Ratio | 37.21 |
| Forward PE | 34.29 |
| PS Ratio | 7.46 |
| PB Ratio | 8.19 |
| P/TBV Ratio | 15.83 |
| P/FCF Ratio | 34.26 |
| P/OCF Ratio | 31.46 |
| PEG Ratio | 3.27 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.19, with an EV/FCF ratio of 33.06.
| EV / Earnings | 35.88 |
| EV / Sales | 7.20 |
| EV / EBITDA | 23.19 |
| EV / EBIT | 26.14 |
| EV / FCF | 33.06 |
Financial Position
The company has a current ratio of 2.22, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.22 |
| Quick Ratio | 1.48 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.16 |
| Debt / FCF | 0.22 |
| Interest Coverage | 55.37 |
Financial Efficiency
Return on equity (ROE) is 23.69% and return on invested capital (ROIC) is 33.35%.
| Return on Equity (ROE) | 23.69% |
| Return on Assets (ROA) | 13.14% |
| Return on Invested Capital (ROIC) | 33.35% |
| Return on Capital Employed (ROCE) | 26.44% |
| Weighted Average Cost of Capital (WACC) | 8.11% |
| Revenue Per Employee | 3.12M |
| Profits Per Employee | 625,902 |
| Employee Count | 2,772 |
| Asset Turnover | 0.76 |
| Inventory Turnover | 1.73 |
Taxes
In the past 12 months, Mycronic AB has paid 485.00 million in taxes.
| Income Tax | 485.00M |
| Effective Tax Rate | 21.84% |
Stock Price Statistics
The stock price has increased by +55.01% in the last 52 weeks. The beta is 0.70, so Mycronic AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | +55.01% |
| 50-Day Moving Average | 316.04 |
| 200-Day Moving Average | 252.21 |
| Relative Strength Index (RSI) | 55.00 |
| Average Volume (20 Days) | 217,749 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Mycronic AB had revenue of SEK 8.65 billion and earned 1.74 billion in profits. Earnings per share was 8.88.
| Revenue | 8.65B |
| Gross Profit | 4.68B |
| Operating Income | 2.38B |
| Pretax Income | 2.22B |
| Net Income | 1.74B |
| EBITDA | 2.59B |
| EBIT | 2.38B |
| Earnings Per Share (EPS) | 8.88 |
Balance Sheet
The company has 2.69 billion in cash and 420.00 million in debt, with a net cash position of 2.27 billion or 11.61 per share.
| Cash & Cash Equivalents | 2.69B |
| Total Debt | 420.00M |
| Net Cash | 2.27B |
| Net Cash Per Share | 11.61 |
| Equity (Book Value) | 7.88B |
| Book Value Per Share | 40.36 |
| Working Capital | 4.03B |
Cash Flow
In the last 12 months, operating cash flow was 2.05 billion and capital expenditures -168.00 million, giving a free cash flow of 1.88 billion.
| Operating Cash Flow | 2.05B |
| Capital Expenditures | -168.00M |
| Depreciation & Amortization | 210.00M |
| Net Borrowing | -109.00M |
| Free Cash Flow | 1.88B |
| FCF Per Share | 9.64 |
Margins
Gross margin is 54.11%, with operating and profit margins of 27.53% and 20.06%.
| Gross Margin | 54.11% |
| Operating Margin | 27.53% |
| Pretax Margin | 25.68% |
| Profit Margin | 20.06% |
| EBITDA Margin | 29.96% |
| EBIT Margin | 27.53% |
| FCF Margin | 21.77% |
Dividends & Yields
This stock pays an annual dividend of 3.25, which amounts to a dividend yield of 0.98%.
| Dividend Per Share | 3.25 |
| Dividend Yield | 0.98% |
| Dividend Growth (YoY) | -13.33% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 36.66% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.98% |
| Earnings Yield | 2.69% |
| FCF Yield | 2.92% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Mycronic AB is 311.50, which is -5.72% lower than the current price. The consensus rating is "Hold".
| Price Target | 311.50 |
| Price Target Difference | -5.72% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 12.64% |
| EPS Growth Forecast (3Y) | 17.85% |
Stock Splits
The last stock split was on June 3, 2025. It was a forward split with a ratio of 2.
| Last Split Date | Jun 3, 2025 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |